Kentucky Retirement Systems Abb Vie Inc. Transaction History

Kentucky Retirement Systems

$3.35 Billion
Q3 2024

A detailed history of Kentucky Retirement Systems transactions in Abb Vie Inc. stock. As of the latest transaction made, Kentucky Retirement Systems holds 123,053 shares of ABBV stock, worth $21.6 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares

123,053

Previous 133,069 7.53%

Holding current value

$21.6 Million

Previous $22.8 Million 6.47%

% of portfolio

0.73%

Previous 0.67%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$163.84 - $199.33 $1.64 Million - $2 Million	-10,016 Reduced 7.53%	123,053 $24.3 Million
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $156,492 - $182,748	-1,011 Reduced 0.75%	133,069 $22.8 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $1.15 Million - $1.31 Million	-7,182 Reduced 5.08%	134,080 $24.4 Million
Q4 2023 Feb 08, 2024	BUY	$137.6 - $154.97 $825,600 - $929,820	6,000 Added 4.44%	141,262 $21.9 Million
Q3 2023 Oct 12, 2023	SELL	$133.59 - $154.65 $880,491 - $1.02 Million	-6,591 Reduced 4.65%	135,262 $20.2 Million
Q2 2023 Aug 07, 2023	BUY	$132.51 - $164.9 $268,200 - $333,757	2,024 Added 1.45%	141,853 $19.1 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $118,435 - $136,396	819 Added 0.59%	139,829 $22.3 Million
Q4 2022 Feb 06, 2023	BUY	$138.31 - $165.87 $83,954 - $100,683	607 Added 0.44%	139,010 $22.5 Million
Q3 2022 Nov 16, 2022	BUY	$134.21 - $153.93 $973,022 - $1.12 Million	7,250 Added 5.53%	138,403 $18.6 Million
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $2.54 Million - $3.23 Million	18,468 Added 16.39%	131,153 $20.1 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $1.03 Million - $1.28 Million	7,808 Added 7.44%	112,685 $18.3 Million
Q4 2021 Feb 04, 2022	BUY	$107.43 - $135.93 $332,388 - $420,567	3,094 Added 3.04%	104,877 $14.2 Million
Q3 2021 Nov 17, 2021	SELL	$106.4 - $120.78 $113,422 - $128,751	-1,066 Reduced 1.04%	101,783 $11 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $943,838 - $1.05 Million	-8,971 Reduced 8.02%	102,849 $11.6 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $24,245 - $26,690	237 Added 0.21%	111,820 $12.1 Million
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $699,055 - $943,798	8,685 Added 8.44%	111,583 $12 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $411,165 - $482,572	4,786 Added 4.88%	102,898 $9.01 Million
Q2 2020 Aug 12, 2020	SELL	$73.37 - $98.18 $211,672 - $283,249	-2,885 Reduced 2.86%	98,112 $9.63 Million
Q1 2020 May 01, 2020	BUY	$64.5 - $97.79 $1.61 Million - $2.44 Million	24,918 Added 32.75%	100,997 $7.7 Million
Q4 2019 Feb 18, 2020	BUY	$72.13 - $90.25 $23,009 - $28,789	319 Added 0.42%	76,079 $6.74 Million
Q3 2019 Nov 05, 2019	BUY	$62.98 - $75.72 $435,443 - $523,528	6,914 Added 10.04%	75,760 $5.74 Million
Q2 2019 Aug 07, 2019	BUY	$65.7 - $83.98 $286,123 - $365,732	4,355 Added 6.75%	68,846 $5.01 Million
Q1 2019 May 22, 2019	SELL	$77.14 - $90.79 $72,511 - $85,342	-940 Reduced 1.44%	64,491 $5.2 Million
Q4 2018 Feb 25, 2019	BUY	$77.85 - $96.01 $73,646 - $90,825	946 Added 1.47%	65,431 $6.03 Million
Q3 2018 Nov 19, 2018	SELL	$88.91 - $98.84 $5.94 Million - $6.61 Million	-66,859 Reduced 50.9%	64,485 $0
Q3 2018 Nov 16, 2018	BUY	$88.91 - $98.84 $5.96 Million - $6.62 Million	67,001 Added 104.13%	131,344 $0
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $1.69 Million - $2 Million	-18,850 Reduced 22.66%	64,343 $5.96 Million
Q1 2018 May 07, 2018	SELL	$92.01 - $123.21 $1.39 Million - $1.86 Million	-15,110 Reduced 15.37%	83,193 $7.87 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $51,944 - $56,961	580 Added 0.59%	98,303 $9.51 Million
Q3 2017 Nov 08, 2017	SELL	$69.85 - $89.22 $300,494 - $383,824	-4,302 Reduced 4.22%	97,723 $8.68 Million
Q2 2017 Aug 18, 2017	BUY	N/A	102,025	102,025 $7.4 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kentucky Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Kentucky Retirement Systems with notifications on news.

Account

Kentucky Retirement Systems Abb Vie Inc. Transaction History